Cargando…

ROS1 copy number alterations are frequent in non-small cell lung cancer

OBJECTIVES: We aimed to determine the prevalence and partners of ROS1 rearrangements, to explore the correlation between FISH and IHC assays, and to investigate clinical implications of ROS1 copy number alterations (CNAs). METHODS: A total of 314 NSCLC patients were screened using ROS1 FISH break-ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clavé, Sergi, Gimeno, Javier, Muñoz-Mármol, Ana M., Vidal, Joana, Reguart, Noemí, Carcereny, Enric, Pijuan, Lara, Menéndez, Sílvia, Taus, Álvaro, Mate, José Luís, Serrano, Sergio, Albanell, Joan, Espinet, Blanca, Arriola, Edurne, Salido, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884972/ https://www.ncbi.nlm.nih.gov/pubmed/26783962 http://dx.doi.org/10.18632/oncotarget.6921

Ejemplares similares

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)
por: Casadevall, David, et al.
Publicado: (2015)

High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients
por: Cañadas, Israel, et al.
Publicado: (2014)

FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors
por: Carracedo, Alma, et al.
Publicado: (2009)

Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer
por: Clavé, Sergi, et al.
Publicado: (2023)

Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry
por: Salido, Marta, et al.
Publicado: (2005)

EGFR-Mutant Lung Adenocarcinoma Mimicking a Pneumonia
por: Taus, Álvaro, et al.
Publicado: (2012)

Multiple Brain Pseudoprogression in a Patient With NSCLC Treated With Pembrolizumab
por: Moliner, Laura, et al.
Publicado: (2020)

Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry
por: Conde, Esther, et al.
Publicado: (2014)

EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2019)

Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)
por: García-Campelo, Rosario, et al.
Publicado: (2023)

SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)
por: García-Campelo, Rosario, et al.
Publicado: (2023)

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines
por: Arriola, E, et al.
Publicado: (2011)

Determining Frequent Patterns of Copy Number Alterations in Cancer
por: Rapaport, Franck, et al.
Publicado: (2010)

Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C
por: Notario, Lucía, et al.
Publicado: (2023)

Frequent copy number variants in a cohort of Mexican-Mestizo individuals
por: Sánchez, Silvia, et al.
Publicado: (2023)

Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small cell lung cancer and no other actionable oncogenic driver
por: Domènech, Marta, et al.
Publicado: (2021)

Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC
por: Rocha, Pedro, et al.
Publicado: (2020)

Advanced lung adenocarcinomas with ROS1-rearrangement frequently show hepatoid cell
por: Zhao, Jing, et al.
Publicado: (2016)

Neoadjuvant treatment of stage IIIA-N2 in EGFR-Mutant/ALK-rearranged non-small cell lung cancer
por: Reyes, Roxana, et al.
Publicado: (2021)

The frequent complete subgraphs in the human connectome
por: Fellner, Máté, et al.
Publicado: (2020)

Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic
por: Rios-Hoyo, Alejandro, et al.
Publicado: (2023)

Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors
por: Lourenço, Nelson, et al.
Publicado: (2014)

The Frequent Network Neighborhood Mapping of the human hippocampus shows much more frequent neighbor sets in males than in females
por: Fellner, Máté, et al.
Publicado: (2020)

Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy
por: Pernía, Olga, et al.
Publicado: (2014)

Possible frequent multiple mitochondrial DNA copies in a single nucleoid in HeLa cells
por: Pavluch, Vojtěch, et al.
Publicado: (2023)

Acquired Mechanisms of Resistance to Osimertinib—The Next Challenge
por: Ríos-Hoyo, Alejandro, et al.
Publicado: (2022)

SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)
por: Majem, M., et al.
Publicado: (2018)

Multiple Components of the VHL Tumor Suppressor Complex Are Frequently Affected by DNA Copy Number Loss in Pheochromocytoma
por: Rowbotham, David A., et al.
Publicado: (2014)

Frequent loss of lineages and deficient duplications accounted for low copy number of disease resistance genes in Cucurbitaceae
por: Lin, Xiao, et al.
Publicado: (2013)

Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN
por: Borge, Kaja S., et al.
Publicado: (2015)

Frequent copy number gains of SLC2A3 and ETV1 in testicular embryonal carcinomas
por: Hoff, Andreas M, et al.
Publicado: (2020)

Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go
por: Puiggros, Anna, et al.
Publicado: (2014)

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer
por: Reguart, Noemí, et al.
Publicado: (2010)

ATM meets ERK5
por: Angulo-Ibáñez, Maria, et al.
Publicado: (2017)

GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors
por: Sriram, Krishna, et al.
Publicado: (2019)

PD-L1 expression testing in non-small cell lung cancer
por: Teixidó, Cristina, et al.
Publicado: (2018)

Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?
por: Plaja, Andrea, et al.
Publicado: (2021)

Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing
por: Conde, Esther, et al.
Publicado: (2022)

Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells
por: Soh, Junichi, et al.
Publicado: (2009)

Microarray Analysis of Copy Number Variants on the Human Y Chromosome Reveals Novel and Frequent Duplications Overrepresented in Specific Haplogroups
por: Johansson, Martin M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7qdtrmrjf3o5mtgtlnioaalkr6